ARCHIVES

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

This article is from The Cancer Letter archive.

Vol. 18 No. 28 | July 10, 1992

Download PDF Visit The Full Archive

Related Articles

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research

March 8, 1991

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011